Status:
COMPLETED
US Inhaled Insulin Therapeutic Choice Questionnaire Study
Lead Sponsor:
Pfizer
Collaborating Sponsors:
Sanofi
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
This is a questionnaire based study (no study drug is involved) that asks if more patients with uncontrolled type 2 diabetes on diabetes pills will choose insulin as the next treatment choice if inhal...
Eligibility Criteria
Inclusion
- Male and female, age \> = 18 years and \<= 80 years with a diagnosis of type 2 diabetes made at least 6 months prior to study entry
- Currently treated with either:
- 2 or more oral antidiabetic agents, OR 1 or more oral antidiabetic agents and insulin glargine
Exclusion
- Type 1 diabetes
- Smoking within the past 6 months
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
End Date :
March 1 2006
Estimated Enrollment :
740 Patients enrolled
Trial Details
Trial ID
NCT00139763
Start Date
July 1 2005
End Date
March 1 2006
Last Update
March 19 2007
Active Locations (42)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Chandler, Arizona, United States, 85224
2
Pfizer Investigational Site
Mesa, Arizona, United States, 85201
3
Pfizer Investigational Site
Phoenix, Arizona, United States, 85006-2850
4
Pfizer Investigational Site
Phoenix, Arizona, United States, 85051